These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 25768866)
1. TB screening among people living with HIV/AIDS in resource-limited settings. Date A; Modi S J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3():S270-3. PubMed ID: 25768866 [TBL] [Abstract][Full Text] [Related]
2. Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature. Briggs MA; Emerson C; Modi S; Taylor NK; Date A J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S297-305. PubMed ID: 25768869 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data. Karanja M; Kingwara L; Owiti P; Kirui E; Ngari F; Kiplimo R; Maina M; Masini E; Onyango E; Ngugi C PLoS One; 2020; 15(12):e0234588. PubMed ID: 33264300 [TBL] [Abstract][Full Text] [Related]
4. Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries. Charles MK; Lindegren ML; Wester CW; Blevins M; Sterling TR; Dung NT; Dusingize JC; Avit-Edi D; Durier N; Castelnuovo B; Nakigozi G; Cortes CP; Ballif M; Fenner L; PLoS One; 2016; 11(4):e0153243. PubMed ID: 27073928 [TBL] [Abstract][Full Text] [Related]
5. Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries. Harries AD; Schwoebel V; Monedero-Recuero I; Aung TK; Chadha S; Chiang CY; Conradie F; Dongo JP; Heldal E; Jensen P; Nyengele JPK; Koura KG; Kumar AMV; Lin Y; Mlilo N; Nakanwagi-Mukwaya A; Ncube RT; Nyinoburyo R; Oo NL; Patel LN; Piubello A; Rusen ID; Sanda T; Satyanarayana S; Syed I; Thu AS; Tonsing J; Trébucq A; Zamora V; Zishiri C; Hinderaker SG; Aït-Khaled N; Roggi A; Caminero Luna J; Graham SM; Dlodlo RA; Fujiwara PI Int J Tuberc Lung Dis; 2019 Feb; 23(2):241-251. PubMed ID: 30808459 [TBL] [Abstract][Full Text] [Related]
6. Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study. Auld AF; Kerkhoff AD; Hanifa Y; Wood R; Charalambous S; Liu Y; Agizew T; Mathoma A; Boyd R; Date A; Shiraishi RW; Bicego G; Mathebula-Modongo U; Alexander H; Serumola C; Rankgoane-Pono G; Pono P; Finlay A; Shepherd JC; Ellerbrock TV; Grant AD; Fielding K PLoS Med; 2021 Sep; 18(9):e1003739. PubMed ID: 34491987 [TBL] [Abstract][Full Text] [Related]
7. Tuberculosis screening improves preventive therapy uptake (TB SCRIPT) trial among people living with HIV in Uganda: a study protocol of an individual randomized controlled trial. Semitala FC; Chaisson LH; Dowdy DW; Armstrong DT; Opira B; Aman K; Kamya M; Phillips PPJ; Yoon C Trials; 2022 May; 23(1):399. PubMed ID: 35550621 [TBL] [Abstract][Full Text] [Related]
8. Using tuberculin skin test as an entry point to screen for latent and active tuberculosis in Thai people living with HIV. Phanuphak N; Varma JK; Kittikraisak W; Teeratakulpisarn N; Phasitlimakul S; Suwanmala P; Pankam T; Burapat T; Tasaneeyapan T; McCarthy KD; Cain KP; Phanuphak P J Acquir Immune Defic Syndr; 2012 Aug; 60(4):384-92. PubMed ID: 22531757 [TBL] [Abstract][Full Text] [Related]
9. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF. Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890 [TBL] [Abstract][Full Text] [Related]
10. Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017). Nabity SA; Gunde LJ; Surie D; Shiraishi RW; Kirking HL; Maida A; Auld AF; Odo M; Jahn A; Nyirenda RK; Oeltmann JE PLoS One; 2021; 16(4):e0248115. PubMed ID: 33793577 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary tuberculosis screening in anti-retroviral treated adults living with HIV in Kenya. Gersh JK; Barnabas RV; Matemo D; Kinuthia J; Feldman Z; Lacourse SM; Mecha J; Warr AJ; Kamene M; Horne DJ BMC Infect Dis; 2021 Feb; 21(1):218. PubMed ID: 33632173 [TBL] [Abstract][Full Text] [Related]
12. Programmatic Evaluation of an Algorithm for Intensified Tuberculosis Case Finding and Isoniazid Preventive Therapy for People Living With HIV in Thailand and Vietnam. Cowger TL; Thai LH; Duong BD; Danyuttapolchai J; Kittimunkong S; Nhung NV; Nhan DT; Monkongdee P; Thoa CK; Khanh VT; Nateniyom S; Yen NTB; Ngoc DV; Thinh T; Whitehead S; Pevzner ES J Acquir Immune Defic Syndr; 2017 Dec; 76(5):512-521. PubMed ID: 29023251 [TBL] [Abstract][Full Text] [Related]
13. Relevance and acceptability of using the Quantiferon gold test (QGIT) to screen CD4 blood draws for latent TB infection among PLHIV in South Africa: formative qualitative research findings from the TEKO trial. Kerrigan D; Tudor C; Motlhaoleng K; Lebina L; Qomfu C; Variava E; Chon S; Martinson N; Golub JE BMC Health Serv Res; 2018 Apr; 18(1):288. PubMed ID: 29661197 [TBL] [Abstract][Full Text] [Related]
14. Review of policy and status of implementation of collaborative HIV-TB activities in 23 high-burden countries. Gupta S; Granich R; Date A; Lepere P; Hersh B; Gouws E; Samb B Int J Tuberc Lung Dis; 2014 Oct; 18(10):1149-58. PubMed ID: 25216827 [TBL] [Abstract][Full Text] [Related]
15. Community-based multi-disease prevention campaigns for controlling human immunodeficiency virus-associated tuberculosis. Suthar AB; Klinkenberg E; Ramsay A; Garg N; Bennett R; Towle M; Sitienei J; Smyth C; Daniels C; Baggaley R; Gunneberg C; Williams B; Getahun H; van Gorkom J; Granich RM Int J Tuberc Lung Dis; 2012 Apr; 16(4):430-6. PubMed ID: 22640510 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the uptake of tuberculosis preventative therapy for people living with HIV in Namibia: a multiple methods analysis. Roscoe C; Lockhart C; de Klerk M; Baughman A; Agolory S; Gawanab M; Menzies H; Jonas A; Salomo N; Taffa N; Lowrance D; Robsky K; Tollefson D; Pevzner E; Hamunime N; Mavhunga F; Mungunda H BMC Public Health; 2020 Dec; 20(1):1838. PubMed ID: 33261569 [TBL] [Abstract][Full Text] [Related]
17. Tuberculosis preventive treatment uptake among people living with HIV during COVID-19 period in Addis Ababa, Ethiopia: a retrospective data review. Gebreegziabher SB; Ashuro AA; Kumssa TH; Teferi MY; Alemayue EA; Datiko DG; Yimer SA; Shagre MB BMC Infect Dis; 2024 May; 24(1):499. PubMed ID: 38760665 [TBL] [Abstract][Full Text] [Related]
18. High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India. Saldanha N; Runwal K; Ghanekar C; Gaikwad S; Sane S; Pujari S BMC Infect Dis; 2019 May; 19(1):391. PubMed ID: 31068153 [TBL] [Abstract][Full Text] [Related]
19. Isoniazid Preventive Therapy for Prevention of Tuberculosis among People Living with HIV in Ethiopia: A Systematic Review of Implementation and Impacts. Assefa DG; Zeleke ED; Bekele D; Ejigu DA; Molla W; Woldesenbet TT; Aynalem A; Abebe M; Mebratu A; Manyazewal T Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612942 [TBL] [Abstract][Full Text] [Related]
20. Tuberculosis case finding and isoniazid preventive therapy among people living with HIV at public health facilities of Addis Ababa, Ethiopia: a cross-sectional facility based study. Denegetu AW; Dolamo BL BMC Public Health; 2014 Jan; 14():52. PubMed ID: 24438508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]